Clinical Trial Update: Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating adult human mesenchymal stem cells for treating acute graft-versus-host disease (GVHD) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Mesoblast adult human mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Mesoblast, Inc. | Conditions: Graft Vs Host Disease | Phase 2 | Status: COMPLETED